Data Monitoring Committees (DMCs) are in place for many clinical studies to help protect the safety of current and potential patients. When DMCs were first introduced, they commonly oversaw large cardiovascular studies, but over the past few decades they have shifted to the oversight of trials in other therapeutic areas, including oncology, immunology, and metabolic and endocrine disorders.

As clinical trials become more complex and the requirement for DMCs increase, Sponsors are looking for trusted partners to independently manage DMC operations across multiple studies or programs to relieve the burden on their teams whilst being confident that patient safety and trial integrity are being safeguarded.

This webinar should prove instructive to organizations that require DMCs for multiple studies and / or programs and are interested in the operational and costs benefits of preferred providers and partnerships.

Key Topics

Entering into a preferred providership and / or partnership can increase efficiency and predictability, ensure consistent quality, and decrease the costs of DMC services. In this webinar we will present and discuss:

1. How partnership / preferred provider models can increase the efficiency of DMC operations,  including competitive pricing models, consistent delivery models, flexible resourcing, and continuous development
2. Practical information on setting up and maintaining a successful partnership / preferred providership and examples around the importance of service agreements, Partnership Operating Documents, and governance for achieving lower costs and consistent delivery across all of a Sponsor’s studies

Speakers

• Liz Gough, Director Portfolio Leadership
• Becky Gatesman, Axio Global Head of Operations